Clinical Study

Rivastigmine as a Symptomatic Treatment for Apathy in Parkinson’s Dementia Complex: New Aspects for This Riddle

Table 7

Apathy scores, AES-C, clinician rated apathy evaluation scale; AES-S, self-report rated apathy evaluation scale. Values are mean (SD). NS = not significant. We report the differences from the cutoff score.

Baseline
cutoff > 37
12- month
cutoff > 37
Within group
baseline/12 months

AES-S+16.3 (4.1)+ 19.9 (2.1)NS
AES-C+15.5 (3.7)+21.5 (2.7)